At a glance
- Originator Wyeth
- Class Neuroprotectants; Nootropics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Alzheimer's disease
Most Recent Events
- 18 Oct 2000 Profile reviewed but no significant modifications made
- 21 Jul 1999 No-Development-Reported for Alzheimer's disease in Belgium (Unknown route)
- 21 Jul 1999 No-Development-Reported for Alzheimer's disease in United Kingdom (Unknown route)